Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines

The function of adjuvant in maintaining the long-term immune response to Typhoid conjugate vaccine (TCV) was evaluated in. Two TCV products, Vi-DT and Vi-TT, were formulated in either aluminum phosphate (AlPO4) or aluminum hydroxide (AlOH) as adjuvants and TCV formulated in phosphate buffer saline w...

Full description

Bibliographic Details
Main Authors: Erman Tritama, Catur Riani, Indra Rudiansyah, Arip Hidayat, Siti Azizah Kharisnaeni, Debbie Sofie Retnoningrum
Format: Article
Language:English
Published: Taylor & Francis Group 2018-06-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2018.1431599
_version_ 1827809922542206976
author Erman Tritama
Catur Riani
Indra Rudiansyah
Arip Hidayat
Siti Azizah Kharisnaeni
Debbie Sofie Retnoningrum
author_facet Erman Tritama
Catur Riani
Indra Rudiansyah
Arip Hidayat
Siti Azizah Kharisnaeni
Debbie Sofie Retnoningrum
author_sort Erman Tritama
collection DOAJ
description The function of adjuvant in maintaining the long-term immune response to Typhoid conjugate vaccine (TCV) was evaluated in. Two TCV products, Vi-DT and Vi-TT, were formulated in either aluminum phosphate (AlPO4) or aluminum hydroxide (AlOH) as adjuvants and TCV formulated in phosphate buffer saline were used as controls. In each case, a group of Balb/c mice was injected intramuscularly with two doses of the formulated vaccine at two-week intervals. The anti-Vi IgG responses were monitored by Enzyme-Linked Immunosorbent Assay and the levels of CD4+ T-cells expressing cytokine were characterized using intracellular cytokine staining. All mice immunized by TCV formulated in adjuvant elicited anti-Vi response to a higher level than the group receiving TCV formulated in PBS. The extent of adsorption of TCV in AlOH was greater than that in AlPO4, and this finding correlated well with the observation that the mice immunized with two doses of Vi-DT(AlOH) elicited anti-Vi IgG to a level higher than that seen with Vi-DT(AlPO4). The mice primed with Vi-TT(AlOH) produced lower anti-Vi IgG (25.901 GM) compared to those receiving Vi-TT(AlPO4) (49.219 GM). However, after the second injection, the former raised the antibody level significantly to 137.008 GM while the latter provided a value of only 104.966 GM. The groups of mice vaccinated by TCV formulated in AlOH expressed IL4 at higher levels than the other groups, which correlated positively with the high Anti-Vi IgG in these animals. In conclusion, AlOH could be recommended as an effective adjuvant for TCV to provide a long-term immune response.
first_indexed 2024-03-11T22:45:39Z
format Article
id doaj.art-520538ada5b34d6bbe8d90655fe9f996
institution Directory Open Access Journal
issn 2164-5515
2164-554X
language English
last_indexed 2024-03-11T22:45:39Z
publishDate 2018-06-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj.art-520538ada5b34d6bbe8d90655fe9f9962023-09-22T08:17:54ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2018-06-011461524152910.1080/21645515.2018.14315991431599Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccinesErman Tritama0Catur Riani1Indra Rudiansyah2Arip Hidayat3Siti Azizah Kharisnaeni4Debbie Sofie Retnoningrum5Laboratory of Pharmaceutical BiotechnologyLaboratory of Pharmaceutical BiotechnologyResearch and Development Division, PT. Bio FarmaResearch and Development Division, PT. Bio FarmaResearch and Development Division, PT. Bio FarmaLaboratory of Pharmaceutical BiotechnologyThe function of adjuvant in maintaining the long-term immune response to Typhoid conjugate vaccine (TCV) was evaluated in. Two TCV products, Vi-DT and Vi-TT, were formulated in either aluminum phosphate (AlPO4) or aluminum hydroxide (AlOH) as adjuvants and TCV formulated in phosphate buffer saline were used as controls. In each case, a group of Balb/c mice was injected intramuscularly with two doses of the formulated vaccine at two-week intervals. The anti-Vi IgG responses were monitored by Enzyme-Linked Immunosorbent Assay and the levels of CD4+ T-cells expressing cytokine were characterized using intracellular cytokine staining. All mice immunized by TCV formulated in adjuvant elicited anti-Vi response to a higher level than the group receiving TCV formulated in PBS. The extent of adsorption of TCV in AlOH was greater than that in AlPO4, and this finding correlated well with the observation that the mice immunized with two doses of Vi-DT(AlOH) elicited anti-Vi IgG to a level higher than that seen with Vi-DT(AlPO4). The mice primed with Vi-TT(AlOH) produced lower anti-Vi IgG (25.901 GM) compared to those receiving Vi-TT(AlPO4) (49.219 GM). However, after the second injection, the former raised the antibody level significantly to 137.008 GM while the latter provided a value of only 104.966 GM. The groups of mice vaccinated by TCV formulated in AlOH expressed IL4 at higher levels than the other groups, which correlated positively with the high Anti-Vi IgG in these animals. In conclusion, AlOH could be recommended as an effective adjuvant for TCV to provide a long-term immune response.http://dx.doi.org/10.1080/21645515.2018.1431599typhoid conjugate vaccineviadjuvanttetanus toxoiddiphteria toxoidanti-vi iggcytokine
spellingShingle Erman Tritama
Catur Riani
Indra Rudiansyah
Arip Hidayat
Siti Azizah Kharisnaeni
Debbie Sofie Retnoningrum
Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines
Human Vaccines & Immunotherapeutics
typhoid conjugate vaccine
vi
adjuvant
tetanus toxoid
diphteria toxoid
anti-vi igg
cytokine
title Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines
title_full Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines
title_fullStr Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines
title_full_unstemmed Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines
title_short Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines
title_sort evaluation of alum based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines
topic typhoid conjugate vaccine
vi
adjuvant
tetanus toxoid
diphteria toxoid
anti-vi igg
cytokine
url http://dx.doi.org/10.1080/21645515.2018.1431599
work_keys_str_mv AT ermantritama evaluationofalumbasedadjuvantontheimmunogenicityofsalmonellaentericaserovartyphiconjugatesvaccines
AT caturriani evaluationofalumbasedadjuvantontheimmunogenicityofsalmonellaentericaserovartyphiconjugatesvaccines
AT indrarudiansyah evaluationofalumbasedadjuvantontheimmunogenicityofsalmonellaentericaserovartyphiconjugatesvaccines
AT ariphidayat evaluationofalumbasedadjuvantontheimmunogenicityofsalmonellaentericaserovartyphiconjugatesvaccines
AT sitiazizahkharisnaeni evaluationofalumbasedadjuvantontheimmunogenicityofsalmonellaentericaserovartyphiconjugatesvaccines
AT debbiesofieretnoningrum evaluationofalumbasedadjuvantontheimmunogenicityofsalmonellaentericaserovartyphiconjugatesvaccines